Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice

Atyabi, Fatemeh; Farkhondehfai, Anahita; Esmaeili, Farnaz; Dinarvand, Rassoul

doi:10.2478/v10007-009-0020-0

Abstract

7-Ethyl-10-hydroxy-camptothecin (SN-38), a metabolite of irinotecan x HCl, is poorly soluble in aqueous solutions and practically insoluble in most physiologically compatible and pharmaceutically acceptable solvents. Formulation of SN-38 in concentrated pharmaceutical delivery systems for parenteral administration is thus very difficult. Due to their biocompatibility and low toxicity, liposomes were considered for the delivery of SN-38. In this study, pegylated liposomes with distearoylphosphatidylcholine, distearoylphosphatidylethanolamine containing SN-38 were prepared and their characteristics, such as particle size, encapsulation efficiency, in vitro drug release and biodistribution, were investigated. The particle size of liposomes was in the range of 150--200 nm. The encapsulation efficiency and in vitro release rate of pegylated liposomes was higher than those of non-pegylated liposomes. As expected, the distribution of pegylated liposomes in body organs such as liver, kidney, spleen and lung was considerably lower than that of non-pegylated liposomes. Also, their blood concentration was at least 50 % higher than that of non-pegylated liposomes.

References

F. Ahmed, V. Vyas, S. Goodin, T. S. Ravikumar, E. H. Rubin and E. Gupta, In vitro activation of Irinotecan to SN-38 by human liver and intestine, Anticancer Res. 19 (1999) 2067--2071.
Search in Google Scholar
C. H. Takimoto and S. G. Arbuck, Topoisomerase I Targeting Agents: The Camptothecins, in Cancer Chemotherapy and Biotherapy: Principles and Practice (Eds. B. A. Chabner and D. L. Longo), 33rd ed. Lippincott Williams & Wilkins, Philadelphia 2001, pp. 579--646.
Search in Google Scholar
R. M. Wadkins, P. M. Potter, B. Vladu, J. Marty, G. Mangold, S. Weitman, G. Manikumar, M. C. Wani, M. E. Wall and D. D. Von Hoff, Water soluble 20(S)-glycinate ester of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts, Cancer Res. 59 (1999) 3424--3428.
Search in Google Scholar
S. Anabousi, M. Laue, C. M. Lehr, U. Bakowsky and C. Ehrhardt, Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy, Eur. J. Pharm. Biopharm. 60 (2005) 295--303; DOI: 10.1016/j.ejpb.2004.12.009.10.1016/j.ejpb.2004.12.009
Search in Google Scholar
S. A. Abraham, D. N. Waterhouse, L. D. Mayer, P. R. Cullis, T. D. Madden and M. B. Bally, The liposomal formulation of doxorubicin, Methods Enzymol. 391 (2005) 71--97; DOI: 10.1016/S0076-6879(05)91004-5.10.1016/S0076-6879(05)91004-5
Search in Google Scholar
S. P. Vyas, S. Quraishi, S. Gupta and K. S. Jaganathan, Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages, Int. J. Pharm. 296 (2005) 2--25; DOI: 10.1016/j.ijpharm.2005.02.003.10.1016/j.ijpharm.2005.02.003
Search in Google Scholar
H. Iinuma, K. Maruyama, K. Okinaga, K. Sasaki, T. Sekine, O. Ishida, N. Ogiwara, K. Johkura and Y. Yonemura, Intracellular targeting therapy of cisplatin-encapsulated transferring-polyethyl-eneglycol liposome on peritoneal dissemination of gastric cancer, Int. J. Cancer 99 (2002) 130--137; DOI: 10.1002/ijc.10242.10.1002/ijc.10242
Search in Google Scholar
R. J. Hong and Y. L. Tseng, Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in partients with solid tumors, Cancer 91 (2001) 1826--1833; DOI: 10.1002/1097-0142(20010501)91:9:1826::AID-CNR1203>3.0.CO,2-J.
Search in Google Scholar
N. Oku, K. Doi, Y. Namba and S. Okada, Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-sarcoma-bearing mice, Int. J. Cancer 58 (1994) 415--419; DOI: 10.1002/ijc.2910580318.10.1002/ijc.2910580318
Search in Google Scholar
Y. Tokudome, N. Oku, K. Doi, Y. Namba and S. Okada, Antitumor activity of vincristin encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma, Biochim. Biophys. Acta 1279 (1996) 70--74; DOI: 10.1016/005-2736(95)00242-1.
Search in Google Scholar
G. L. Berestein, L. Kasi, M. G. Rosemblum, T. Haynie M. Jahns, H. Glenn, R. Mehta, G. M. Mavlight and E. M. Hersh, Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer, Cancer Res. 44 (1984) 375--378.
Search in Google Scholar
K. Shimada, A. Miyagishima, Y. Sadzuka, Y. Nozawa and S. Hirota, Determination of the thickness of fixed aqueous layer around the polyethleneglycol-coated liposomes, J. Drug Target. 3 (1995) 283--289.
Search in Google Scholar
T. Yuda, Y. Pongpaibul, K. Maruyama and M. Iwatatsuru, Prolongation of liposome circulation time by various derivatives of polyethyleneglycols, Bio. Pharm. Bull. 19 (1996) 1347--1351.
Search in Google Scholar
V. P. Torchilin, V. G. Omelyanenko, M. I. Papisov, A. A. Bogdanov, V. S. Trubetsloy, J. N. Herron and C. A. Gentry, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymercoated liposome longevity, Biochem. Biophys. Acta 1195 (1994) 11--20; DOI: 10.1016/005-2736(94) 90003-5.
Search in Google Scholar
J. Janzen, X. Song and D. E. Brooks, Interfacial thickness of liposomes containing poly(ethylene glycol)-cholesterol from electrophoresis, Biophys. J. 70 (1996) 313--320; DOI: 10.1016/S0006-3495 (96)79572-3.
Search in Google Scholar
A. A. Gabizon, H. Shameeda and S. Zalpisky, Pros and cons of the liposome platform in cancer drug targeting, J. Liposome Res. 16 (2006) 175--183; DOI: 10.1080/08982100600848769.10.1080/08982100600848769
Search in Google Scholar
Y. Sadzuka, H. Takabe and T. Sonobe, Liposomalization of SN-38 as active metabolite of CPT-11, J. Control. Rel. 108 (2005) 453--459; DOI: 10.1016/j.jconrel.2005.08.023.10.1016/j.jconrel.2005.08.023
Search in Google Scholar
A. L. Klibanov, K. Maruyama, V. P. Torchilin and L. Huang, Amphipatic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS. J. 268 (1990) 235--237; DOI: 10.1016/0014-5793(90)81016-H.10.1016/0014-5793(90)81016-H
Search in Google Scholar
T. Xuana, J. A. Zhang and I. Ahmad, HPLC method for determination of SN-38 content and SN-38 entrapment efficiency in a novel liposome-based formulation, LE-SN-38, J. Pharm. Biomed. Anal. 41 (2006) 582--588; DOI: 10.1016/j.jpba.2005.10.051.10.1016/j.jpba.2005.10.05116386867
Search in Google Scholar
E. B. Denkbas, X. Kaitianm, A. Tuncel and E. Piskin, Rifampicin-carrying poly(D, L-lactide) microspheres: loading and release, J. Biomat. Sci-Polym. Ed. 6 (1995) 815--825; DOI: 10.1163/156856295X00201.10.1163/156856295X002017772568
Search in Google Scholar
K. Yoncheva, E. Lizarraga and J. M. Irache, Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties, Eur. J. Pharm. Sci. 24 (2005) 411--419; DOI: 10.1016/j.ejps.2004.12.002.10.1016/j.ejps.2004.12.002
Search in Google Scholar
F. Esmaeili, M. H. Ghahremani, B. Esmaeili, M. R. Khoshayand, F. Atyabi and R. Dinarvand, PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution, Int. J. Pharm. 349 (2008) 249--55; DOI: 10.1016/j.ijpharm.2007.07.038.10.1016/j.ijpharm.2007.07.038
Search in Google Scholar
J. M. Harris, N. E. Martin and M. Modi, Pegylation: A novel process for modifying pharmacokinetics, Clin. Pharmacokinet. 40 (2001) 539--551.
Search in Google Scholar
L. Mu and S. S. Feng, Vitamin E TPGS used as emulsi.er in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxols), J. Control. Rel. 80 (2002) 129--144; DOI: 10.1016/S0168-3659(02)00025-1.10.1016/S0168-3659(02)00025-1
Search in Google Scholar
C. Dubernet, Thermoanalysis of microspheres, Thermochim. Acta 248 (1995) 259--269; DOI; 10.1016/0040-6031(94)01947-F.10.1016/0040-6031(94)01947-F
Search in Google Scholar
B. Magenheim, M. Y. Levy and S. Benita, A new in vitro technique for evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure, Int. J. Pharm. 94 (1993) 115--123; DOI: 10.1016/0378-5173(93)90015-8.10.1016/0378-5173(93)90015-8
Search in Google Scholar

Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice

Abstract

Paradigm

My account